Back to Journals » OncoTargets and Therapy » Volume 14
Original Research
Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,580 | Dovepress* | 4,755+ | 609 | 5,364 | |
PubMed Central* | 825 | 313 | 1,138 | ||
Totals | 5,580 | 922 | 6,502 | ||
*Since 2 July 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
19 | 0 | 0 | 0 | 9 | 10 |
View citations on PubMed Central and Google Scholar